CAS: 366017-09-6 - Mubritinib
Fórmula:C25H23F3N4O2
InChI:InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+
Chave InChI:InChIKey=ZTFBIUXIQYRUNT-MDWZMJQESA-N
SMILES:FC(F)(F)C1=CC=C(C=CC2=NC(=CO2)COC3=CC=C(C=C3)CCCCN4N=NC=C4)C=C1
- Sinónimos:
- 1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
- 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole
- 1H-1,2,3-Triazole, 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-
- Tak 165
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Mubritinib REF: IN-DA0078T8CAS: 366017-09-6 | 98% | 81,00 €~328,00 € | Ter 07 Jan 25 | |
Mubritinib REF: 7W-GP2351CAS: 366017-09-6 | ≥ 95.0% | A consultar | Ter 07 Jan 25 | |
Mubritinib REF: 3B-M3058CAS: 366017-09-6 | >98.0%(HPLC) | 211,00 €~687,00 € | Ter 07 Jan 25 | |
Mubritinib REF: TM-T6124CAS: 366017-09-6 | 99.85% - 99.87% | 54,00 €~1.270,00 € | Seg 13 Jan 25 | |
Mubritinib REF: 3D-FM32802CAS: 366017-09-6 | Min. 95% | A consultar | Ter 18 Fev 25 |
Mubritinib
- Antitumoral
- Activadores e Inibidores de Enzimas
- Ingredientes Farmacêuticos Activos (API) para investigação
- Enzimas
- Ver mais categorias
- EGFR
- Neurociência
- Tirosina Quinase/Adaptador
- Investigação do cancro
- Ingredientes Farmacêuticos Activos (API) para investigação
- Bioquímicos e reagentes
- Biologia Celular e Molecular
Ref: IN-DA0078T8
5mg | 81,00 € | ||
10mg | 111,00 € | ||
50mg | 328,00 € |
Mubritinib
Ref: 7W-GP2351
Tamanho indefinido | A consultar |
Mubritinib
Ref: 3B-M3058
25mg | 211,00 € | ||
100mg | 687,00 € |
Mubritinib
Ref: TM-T6124
5mg | 189,00 € | ||
10mg | 287,00 € | ||
25mg | 544,00 € | ||
50mg | 772,00 € | ||
100mg | 1.270,00 € | ||
1mL*10mM (DMSO) | 270,00 € |
Mubritinib
Ref: 3D-FM32802
10mg | A consultar | ||
50mg | A consultar |